Literature DB >> 28990242

Blood utilization in revision versus first-time cardiac surgery: an update in the era of patient blood management.

Nadia B Hensley1, Megan P Kostibas1, William W Yang1, Todd C Crawford2, Kaushik Mandal2, Pranjal B Gupta3, Steven M Frank4, Charles H Brown1.   

Abstract

BACKGROUND: Relative to first-time (primary) cardiac surgery, revision cardiac surgery is associated with increased transfusion requirements, but studies comparing these cohorts were performed before patient blood management (PBM) and blood conservation measures were commonplace. The current study was performed as an update to determine if this finding is still evident in the PBM era. STUDY DESIGN AND METHODS: Primary and revision cardiac surgery cases were compared in a retrospective database analysis at a single tertiary care referral center. Two groups of patients were assessed: 1) those having isolated coronary artery bypass (CAB) or valve surgery and 2) all other cardiac surgeries. Intraoperative and whole hospital transfusion requirements were assessed for the four major blood components.
RESULTS: Compared to the primary cardiac surgery patients, the revision surgery patients required approximately twofold more transfused units intraoperatively (p < 0.0001) and approximately two- to threefold more transfused units for the whole hospital stay (p < 0.0001). Intraoperative massive transfusion (>10 red blood cell [RBC] units) was substantially more frequent with revision versus primary cardiac surgery (2.6% vs. 0.1% [p < 0.0001] for isolated CAB or valve and 6.1% vs. 1.9% [p < 0.0001] for all other cardiac surgeries). Revision surgery was an independent risk factor for both moderate (6-10 RBC units) and massive intraoperative transfusion.
CONCLUSIONS: In the era of PBM, with restrictive transfusion strategies and a variety of methods for blood conservation, revision cardiac surgery patients continue to have substantially greater transfusion requirements relative to primary cardiac surgery patients. This difference in transfusion requirement was greater than what has been previously reported in the pre-PBM era.
© 2017 AABB.

Entities:  

Mesh:

Year:  2017        PMID: 28990242      PMCID: PMC6519923          DOI: 10.1111/trf.14361

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  23 in total

1.  Cardiac surgery after mediastinal radiation: extent of exposure influences outcome.

Authors:  Albert S Y Chang; Nicholas G Smedira; Catherine L Chang; Monica M Benavides; Ulf Myhre; Jingyuan Feng; Eugene H Blackstone; Bruce W Lytle
Journal:  J Thorac Cardiovasc Surg       Date:  2007-01-08       Impact factor: 5.209

2.  Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery.

Authors:  Roman M Sniecinski; Edward P Chen; Kenichi A Tanaka
Journal:  Blood Coagul Fibrinolysis       Date:  2008-03       Impact factor: 1.276

3.  Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome.

Authors:  A W Bracey; R Radovancevic; S A Riggs; S Houston; H Cozart; W K Vaughn; B Radovancevic; H A McAllister; D A Cooley
Journal:  Transfusion       Date:  1999-10       Impact factor: 3.157

4.  Pharmacokinetics of epsilon-aminocaproic acid in patients undergoing aortocoronary bypass surgery.

Authors:  J Butterworth; R L James; Y Lin; R C Prielipp; A S Hudspeth
Journal:  Anesthesiology       Date:  1999-06       Impact factor: 7.892

Review 5.  Cell salvage for minimising perioperative allogeneic blood transfusion.

Authors:  Paul A Carless; David A Henry; Annette J Moxey; Dianne O'Connell; Tamara Brown; Dean A Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

6.  Predictors of homologous blood transfusion for patients undergoing open heart surgery.

Authors:  J Litmathe; U Boeken; P Feindt; E Gams
Journal:  Thorac Cardiovasc Surg       Date:  2003-02       Impact factor: 1.827

7.  Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting.

Authors:  Colleen Gorman Koch; Liang Li; Andra I Duncan; Tomislav Mihaljevic; Delos M Cosgrove; Floyd D Loop; Norman J Starr; Eugene H Blackstone
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

Review 8.  The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials.

Authors:  Guyan Wang; Daniel Bainbridge; Janet Martin; Davy Cheng
Journal:  Anesth Analg       Date:  2009-08       Impact factor: 5.108

9.  Multivariate predictors of blood product use in cardiac surgery.

Authors:  K Gage Parr; Minalkumar A Patel; Rene Dekker; Raia Levin; Robert Glynn; Jerry Avorn; David S Morse
Journal:  J Cardiothorac Vasc Anesth       Date:  2003-04       Impact factor: 2.628

Review 10.  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.

Authors:  D A Henry; P A Carless; A J Moxey; D O'Connell; B J Stokes; B McClelland; A Laupacis; D Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more
  1 in total

1.  The Effect of Standardizing Autologous Prime Techniques in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass.

Authors:  Alfred H Stammers; Stephen Francis; Eric A Tesdahl; Randi Miller; Anthony Nostro; Linda B Mongero
Journal:  J Extra Corpor Technol       Date:  2019-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.